Home > Insider Trading > Filing (0000899243-20-004242)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1793294	Ppd Inc.	PPD	Services-Commercial Physical & Biological Research (8731)	453806427

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1801814	Christopher Fikry	C/O Ppd, Inc. 929 North Front Street Wilmington NC 28401	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Non-Voting Common Stock	Disposition	2020-02-10	6,645	$0.00	0	No	4	D	Direct
Common Stock	Acquisiton	2020-02-10	6,645	$0.00	6,645	No	4	A	Direct
Common Stock	Acquisiton	2020-02-10	7,400	$27.00	14,045	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	D	Direct
No	4	A	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Non-Voting Common Stock	Stock Options (Right to Buy)	Acquisiton	2019-11-26	40,093	$0.00	40,093	$21.70

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
40,093		2029-11-26	No	4	A	Direct

Footnotes

Upon the completion of the initial public offering of PPD, Inc. (the "Issuer"), all shares of the Issuer's non-voting common stock automatically converted into shares of the Issuer's voting common stock on a one-for-one basis.
Shares were acquired in a directed share program in connection with the Issuer's initial public offering.
Represents stock options previously granted to the reporting person on November 26, 2019. These stock options were already reflected on the reporting person's previously filed Form 3.
Represents 29,032 stock options which are unvested and will vest in equal annual installments on November 26, 2020, November 26, 2021, November 26, 2022, November 26, 2023 and November 26, 2024 and 11,061 unvested stock options which are eligible to vest upon the achievement of certain return on capital or rate of return conditions three years after the initial public offering of the Issuer or earlier, upon certain sales by significant stockholders. Does not include an additional 29,032 stock options with an exercise price of $21.70 which are eligible to vest upon the achievement of certain EBITDA-based vesting conditions for fiscal years 2020-2024.